We are live on ! Find out more
BDS

Banco de Sabadell Portfolio holdings

AUM $170M
1-Year Est. Return 26.61%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+26.61%
3 Year Est. Return
+75.08%
5 Year Est. Return
+103.03%
10 Year Est. Return
AUM
$149M
AUM Growth
-$1.41M
Cap. Flow
-$3.93M
Cap. Flow %
-2.64%
Top 10 Hldgs %
31.79%
Holding
129
New
8
Increased
26
Reduced
53
Closed
34

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.05M
2
META icon
Meta Platforms (Facebook)
META
+$2.14M
3
BKNG icon
Booking.com
BKNG
+$2.12M
4
CRM icon
Salesforce
CRM
+$1.99M
5
CVX icon
Chevron
CVX
+$1.74M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.1M
2
JPM icon
JPMorgan Chase
JPM
+$2.07M
3
CAT icon
Caterpillar
CAT
+$1.92M
4
IHI icon
iShares US Medical Devices ETF
IHI
+$1.89M
5
NEM icon
Newmont
NEM
+$1.61M

Sector Composition

Rank Sector Weight
1 Technology 23.22%
2 Financials 15.52%
3 Healthcare 14.67%
4 Consumer Discretionary 11.07%
5 Consumer Staples 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
51
Intel
INTC
$509B
$1.3M 0.87%
24,426
-119
-0.5% -$6.45K
COP icon
52
ConocoPhillips
COP
$144B
$1.26M 0.85%
+6,083
New +$351K
ROST icon
53
Ross Stores
ROST
$80.5B
$1.23M 0.82%
11,218
-58
-0.5% -$6.95K
KO icon
54
Coca-Cola
KO
$372B
$1.21M 0.81%
22,945
-86
-0.4% -$4.79K
VLO icon
55
Valero Energy
VLO
$88.9B
$1.14M 0.77%
16,215
-184
-1% -$12.2K
ADI icon
56
Analog Devices
ADI
$185B
$1.14M 0.76%
+6,782
New +$1.14M
NVO
57
Novo Nordisk
NVO
$196B
$1.1M 0.74%
22,874
-1,694
-7% -$81.9K
AMGN icon
58
Amgen
AMGN
$210B
$978K 0.66%
4,591
+13
+0.3% +$2.99K
DEO icon
59
Diageo
DEO
$48.8B
$930K 0.63%
4,828
+118
+3% +$22.9K
RELX icon
60
RELX
RELX
$64.2B
$858K 0.58%
29,861
-1,644
-5% -$48.4K
TEL icon
61
TE Connectivity
TEL
$62.9B
$852K 0.57%
6,222
-1,307
-17% -$189K
ABB
62
DELISTED
ABB Ltd
ABB
$770K 0.52%
22,991
+462
+2% +$16.8K
UL icon
63
Unilever
UL
$138B
$730K 0.49%
12,002
-723
-6% -$46.1K
IHI icon
64
iShares US Medical Devices ETF
IHI
$3.36B
$708K 0.48%
799
-29,693
-97% -$1.89M
SNY icon
65
Sanofi
SNY
$102B
$661K 0.44%
13,639
-804
-6% -$40.9K
EQNR icon
66
Equinor
EQNR
$93.1B
$656K 0.44%
25,644
-1,319
-5% -$28.2K
BTI icon
67
British American Tobacco
BTI
$128B
$648K 0.44%
18,367
-1,119
-6% -$42K
LIN icon
68
Linde
LIN
$223B
$634K 0.43%
2,162
+118
+6% +$35.9K
RDS.A
69
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$602K 0.4%
13,547
-787
-5% -$31.8K
NVS icon
70
Novartis
NVS
$291B
$492K 0.33%
6,045
-332
-5% -$29.9K
GOOG icon
71
Alphabet (Google) Class C
GOOG
$4.59T
$487K 0.33%
12,720
+7,400
+139% +$1.02M
NVT icon
72
nVent Electric
NVT
$26.3B
$352K 0.24%
10,904
-583
-5% -$18.9K
ALV icon
73
Autoliv
ALV
$9.12B
$351K 0.24%
4,105
-228
-5% -$21K
GSK icon
74
GSK
GSK
$103B
$343K 0.23%
7,162
-428
-6% -$21.5K
AZN icon
75
AstraZeneca
AZN
$241B
$328K 0.22%
2,719
-158
-5% -$18.4K

Similar funds

Banco de Sabadell's Q3 2021 Portfolio in Review

As of Q3 2021, Banco de Sabadell held 129 positions worth $149M, down 0.94% from $150M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Banco de Sabadell's Q3 2021 filing shows 8 new, 26 increased, 53 reduced and 34 closed positions. Its largest new stake was Meta Platforms (Facebook): 5,929 shares worth $2.02M. The largest sale was UnitedHealth, an estimated $2.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Banco de Sabadell's largest Q3 2021 buy was Meta Platforms (Facebook): 5,929 shares worth $2.02M.
  • Banco de Sabadell added most to Johnson & Johnson in Q3 2021, an estimated $3.05M increase.
  • Banco de Sabadell's biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $2.1M.
  • Banco de Sabadell fully exited Caterpillar in Q3 2021, selling an estimated $1.92M.
  • Banco de Sabadell's ten largest holdings make up 32% of its $149M portfolio in Q3 2021.
  • Banco de Sabadell opened 8 new positions and closed 34 in Q3 2021.
  • Banco de Sabadell's portfolio value fell 0.94% quarter-over-quarter to $149M.

Based on Banco de Sabadell's 13F filing for Q3 2021, filed 4 Nov 2021.